Cargando…
Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India
Of patients with multidrug-resistant tuberculosis (MDR TB), <50% complete treatment. Most treatment failures for patients with MDR TB are due to death during TB treatment. We sought to determine the proportion of deaths during MDR TB treatment attributable to TB itself. We used a structured verba...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823351/ https://www.ncbi.nlm.nih.gov/pubmed/29460737 http://dx.doi.org/10.3201/eid2403.171718 |
_version_ | 1783301860740825088 |
---|---|
author | Naik, Poonam Ramesh Moonan, Patrick K. Nirgude, Abhay Subhashrao Shewade, Hemant Deepak Satyanarayana, Srinath Raghuveer, Pracheth Parmar, Malik Ravichandra, Chinnappareddy Singarajipura, Anil |
author_facet | Naik, Poonam Ramesh Moonan, Patrick K. Nirgude, Abhay Subhashrao Shewade, Hemant Deepak Satyanarayana, Srinath Raghuveer, Pracheth Parmar, Malik Ravichandra, Chinnappareddy Singarajipura, Anil |
author_sort | Naik, Poonam Ramesh |
collection | PubMed |
description | Of patients with multidrug-resistant tuberculosis (MDR TB), <50% complete treatment. Most treatment failures for patients with MDR TB are due to death during TB treatment. We sought to determine the proportion of deaths during MDR TB treatment attributable to TB itself. We used a structured verbal autopsy tool to interview family members of patients who died during MDR TB treatment in India during January–December 2016. A committee triangulated information from verbal autopsy, death certificate, or other medical records available with the family members to ascertain the underlying cause of death. For 66% of patient deaths (47/71), TB was the underlying cause of death. We assigned TB as the underlying cause of death for an additional 6 patients who died of suicide and 2 of pulmonary embolism. Deaths during TB treatment signify program failure; accurately determining the cause of death is the first step to designing appropriate, timely interventions to prevent premature deaths. |
format | Online Article Text |
id | pubmed-5823351 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-58233512018-03-01 Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India Naik, Poonam Ramesh Moonan, Patrick K. Nirgude, Abhay Subhashrao Shewade, Hemant Deepak Satyanarayana, Srinath Raghuveer, Pracheth Parmar, Malik Ravichandra, Chinnappareddy Singarajipura, Anil Emerg Infect Dis Research Of patients with multidrug-resistant tuberculosis (MDR TB), <50% complete treatment. Most treatment failures for patients with MDR TB are due to death during TB treatment. We sought to determine the proportion of deaths during MDR TB treatment attributable to TB itself. We used a structured verbal autopsy tool to interview family members of patients who died during MDR TB treatment in India during January–December 2016. A committee triangulated information from verbal autopsy, death certificate, or other medical records available with the family members to ascertain the underlying cause of death. For 66% of patient deaths (47/71), TB was the underlying cause of death. We assigned TB as the underlying cause of death for an additional 6 patients who died of suicide and 2 of pulmonary embolism. Deaths during TB treatment signify program failure; accurately determining the cause of death is the first step to designing appropriate, timely interventions to prevent premature deaths. Centers for Disease Control and Prevention 2018-03 /pmc/articles/PMC5823351/ /pubmed/29460737 http://dx.doi.org/10.3201/eid2403.171718 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Naik, Poonam Ramesh Moonan, Patrick K. Nirgude, Abhay Subhashrao Shewade, Hemant Deepak Satyanarayana, Srinath Raghuveer, Pracheth Parmar, Malik Ravichandra, Chinnappareddy Singarajipura, Anil Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India |
title | Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India |
title_full | Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India |
title_fullStr | Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India |
title_full_unstemmed | Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India |
title_short | Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India |
title_sort | use of verbal autopsy to determine underlying cause of death during treatment of multidrug-resistant tuberculosis, india |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823351/ https://www.ncbi.nlm.nih.gov/pubmed/29460737 http://dx.doi.org/10.3201/eid2403.171718 |
work_keys_str_mv | AT naikpoonamramesh useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia AT moonanpatrickk useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia AT nirgudeabhaysubhashrao useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia AT shewadehemantdeepak useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia AT satyanarayanasrinath useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia AT raghuveerpracheth useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia AT parmarmalik useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia AT ravichandrachinnappareddy useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia AT singarajipuraanil useofverbalautopsytodetermineunderlyingcauseofdeathduringtreatmentofmultidrugresistanttuberculosisindia |